Pharmaceutical makers participating in the Pathogen Access and Benefit Sharing system will make pandemic-related health products available to WHO, playing a key role in ensuring equitable and timely access.
2 min read20 May 2025The idea that the pandemic’s origins lie with a research facility in China was once labeled a conspiracy theory. Disagreements among intelligence experts on the issue ran deeper than is publicly known.
13 min read26 Dec 2024UK Chancellor of the Exchequer Rachel Reeves will set aside billions of pounds for the National Health Service in her budget next week as the institution kicks off an extensive program of reform.
2 min read21 Oct 2024The drugmaker has cut costs already and has no coming product approvals or research that could offer a quick lift.
4 min read8 Oct 2024RTX-CEO/ (UPDATE 2):UPDATE 2-RTX sees labor challenges, exploring alternatives to China suppliers
2 min read11 Sep 2024Moderna is spending aggressively to broaden the uses of its mRNA technology. Investors are losing patience.
3 min read6 Sep 2024At the end of July 2020, as the Covid-19 pandemic raged and unprecedented supply-chain challenges distorted markets, then-Ford Motor Co. Chief Executive Jim Hackett started the company’s earnings call not with financials or strategy but with a message on racial justice and the murder of George Floyd.
3 min read31 Aug 2024USA-FED/JACKSON HOLE-TREASURIES (UPDATE 1):UPDATE 1-U.S. Treasuries not the safe bet they once were, research says
3 min read24 Aug 2024India's total COVID-19 cases count stands at 4.50 crore, and recoveries have increased to 4.44 crore
2 min read19 Dec 2023In a rapidly rising interest rate environment, even a cautiously leveraged company may find itself heavily leveraged.
3 min read10 Oct 2023